Tau Modulates mRNA Transcription, Alternative Polyadenylation Profiles of hnRNPs, Chromatin Remodeling and Spliceosome Complexes

Tau protein is a known contributor in several neurodegenerative diseases, including Alzheimer’s disease (AD) and frontotemporal dementia (FTD). It is well-established that tau forms pathological aggregates and fibrils in these diseases. Tau has been observed within the nuclei of neurons, but there i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mauro Montalbano, Elizabeth Jaworski, Stephanie Garcia, Anna Ellsworth, Salome McAllen, Andrew Routh, Rakez Kayed
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
tau
Acceso en línea:https://doaj.org/article/e82630aa9dc645a094f19b3dcebd97b6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e82630aa9dc645a094f19b3dcebd97b6
record_format dspace
spelling oai:doaj.org-article:e82630aa9dc645a094f19b3dcebd97b62021-12-03T06:25:29ZTau Modulates mRNA Transcription, Alternative Polyadenylation Profiles of hnRNPs, Chromatin Remodeling and Spliceosome Complexes1662-509910.3389/fnmol.2021.742790https://doaj.org/article/e82630aa9dc645a094f19b3dcebd97b62021-12-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fnmol.2021.742790/fullhttps://doaj.org/toc/1662-5099Tau protein is a known contributor in several neurodegenerative diseases, including Alzheimer’s disease (AD) and frontotemporal dementia (FTD). It is well-established that tau forms pathological aggregates and fibrils in these diseases. Tau has been observed within the nuclei of neurons, but there is a gap in understanding regarding the mechanism by which tau modulates transcription. We are interested in the P301L mutation of tau, which has been associated with FTD and increased tau aggregation. Our study utilized tau-inducible HEK (iHEK) cells to reveal that WT and P301L tau distinctively alter the transcription and alternative polyadenylation (APA) profiles of numerous nuclear precursors mRNAs, which then translate to form proteins involved in chromatin remodeling and splicing. We isolated total mRNA before and after over-expressing tau and then performed Poly(A)-ClickSeq (PAC-Seq) to characterize mRNA expression and APA profiles. We characterized changes in Gene Ontology (GO) pathways using EnrichR and Gene Set Enrichment Analysis (GSEA). We observed that P301L tau up-regulates genes associated with reactive oxygen species responsiveness as well as genes involved in dendrite, microtubule, and nuclear body/speckle formation. The number of genes regulated by WT tau is greater than the mutant form, which indicates that the P301L mutation causes loss-of-function at the transcriptional level. WT tau up-regulates genes contributing to cytoskeleton-dependent intracellular transport, microglial activation, microtubule and nuclear chromatin organization, formation of nuclear bodies and speckles. Interestingly, both WT and P301L tau commonly down-regulate genes responsible for ubiquitin-proteosome system. In addition, WT tau significantly down-regulates several genes implicated in chromatin remodeling and nucleosome organization. Although there are limitations inherent to the model systems used, this study will improve understanding regarding the nuclear impact of tau at the transcriptional and post-transcriptional level. This study also illustrates the potential impact of P301L tau on the human brain genome during early phases of pathogenesis.Mauro MontalbanoMauro MontalbanoElizabeth JaworskiStephanie GarciaStephanie GarciaAnna EllsworthAnna EllsworthSalome McAllenSalome McAllenAndrew RouthAndrew RouthRakez KayedRakez KayedFrontiers Media S.A.articlealternative polyadenylationfrontal temporal dementiagene ontologygene set enrichment analysistauneurodegenarationNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENFrontiers in Molecular Neuroscience, Vol 14 (2021)
institution DOAJ
collection DOAJ
language EN
topic alternative polyadenylation
frontal temporal dementia
gene ontology
gene set enrichment analysis
tau
neurodegenaration
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle alternative polyadenylation
frontal temporal dementia
gene ontology
gene set enrichment analysis
tau
neurodegenaration
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Mauro Montalbano
Mauro Montalbano
Elizabeth Jaworski
Stephanie Garcia
Stephanie Garcia
Anna Ellsworth
Anna Ellsworth
Salome McAllen
Salome McAllen
Andrew Routh
Andrew Routh
Rakez Kayed
Rakez Kayed
Tau Modulates mRNA Transcription, Alternative Polyadenylation Profiles of hnRNPs, Chromatin Remodeling and Spliceosome Complexes
description Tau protein is a known contributor in several neurodegenerative diseases, including Alzheimer’s disease (AD) and frontotemporal dementia (FTD). It is well-established that tau forms pathological aggregates and fibrils in these diseases. Tau has been observed within the nuclei of neurons, but there is a gap in understanding regarding the mechanism by which tau modulates transcription. We are interested in the P301L mutation of tau, which has been associated with FTD and increased tau aggregation. Our study utilized tau-inducible HEK (iHEK) cells to reveal that WT and P301L tau distinctively alter the transcription and alternative polyadenylation (APA) profiles of numerous nuclear precursors mRNAs, which then translate to form proteins involved in chromatin remodeling and splicing. We isolated total mRNA before and after over-expressing tau and then performed Poly(A)-ClickSeq (PAC-Seq) to characterize mRNA expression and APA profiles. We characterized changes in Gene Ontology (GO) pathways using EnrichR and Gene Set Enrichment Analysis (GSEA). We observed that P301L tau up-regulates genes associated with reactive oxygen species responsiveness as well as genes involved in dendrite, microtubule, and nuclear body/speckle formation. The number of genes regulated by WT tau is greater than the mutant form, which indicates that the P301L mutation causes loss-of-function at the transcriptional level. WT tau up-regulates genes contributing to cytoskeleton-dependent intracellular transport, microglial activation, microtubule and nuclear chromatin organization, formation of nuclear bodies and speckles. Interestingly, both WT and P301L tau commonly down-regulate genes responsible for ubiquitin-proteosome system. In addition, WT tau significantly down-regulates several genes implicated in chromatin remodeling and nucleosome organization. Although there are limitations inherent to the model systems used, this study will improve understanding regarding the nuclear impact of tau at the transcriptional and post-transcriptional level. This study also illustrates the potential impact of P301L tau on the human brain genome during early phases of pathogenesis.
format article
author Mauro Montalbano
Mauro Montalbano
Elizabeth Jaworski
Stephanie Garcia
Stephanie Garcia
Anna Ellsworth
Anna Ellsworth
Salome McAllen
Salome McAllen
Andrew Routh
Andrew Routh
Rakez Kayed
Rakez Kayed
author_facet Mauro Montalbano
Mauro Montalbano
Elizabeth Jaworski
Stephanie Garcia
Stephanie Garcia
Anna Ellsworth
Anna Ellsworth
Salome McAllen
Salome McAllen
Andrew Routh
Andrew Routh
Rakez Kayed
Rakez Kayed
author_sort Mauro Montalbano
title Tau Modulates mRNA Transcription, Alternative Polyadenylation Profiles of hnRNPs, Chromatin Remodeling and Spliceosome Complexes
title_short Tau Modulates mRNA Transcription, Alternative Polyadenylation Profiles of hnRNPs, Chromatin Remodeling and Spliceosome Complexes
title_full Tau Modulates mRNA Transcription, Alternative Polyadenylation Profiles of hnRNPs, Chromatin Remodeling and Spliceosome Complexes
title_fullStr Tau Modulates mRNA Transcription, Alternative Polyadenylation Profiles of hnRNPs, Chromatin Remodeling and Spliceosome Complexes
title_full_unstemmed Tau Modulates mRNA Transcription, Alternative Polyadenylation Profiles of hnRNPs, Chromatin Remodeling and Spliceosome Complexes
title_sort tau modulates mrna transcription, alternative polyadenylation profiles of hnrnps, chromatin remodeling and spliceosome complexes
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/e82630aa9dc645a094f19b3dcebd97b6
work_keys_str_mv AT mauromontalbano taumodulatesmrnatranscriptionalternativepolyadenylationprofilesofhnrnpschromatinremodelingandspliceosomecomplexes
AT mauromontalbano taumodulatesmrnatranscriptionalternativepolyadenylationprofilesofhnrnpschromatinremodelingandspliceosomecomplexes
AT elizabethjaworski taumodulatesmrnatranscriptionalternativepolyadenylationprofilesofhnrnpschromatinremodelingandspliceosomecomplexes
AT stephaniegarcia taumodulatesmrnatranscriptionalternativepolyadenylationprofilesofhnrnpschromatinremodelingandspliceosomecomplexes
AT stephaniegarcia taumodulatesmrnatranscriptionalternativepolyadenylationprofilesofhnrnpschromatinremodelingandspliceosomecomplexes
AT annaellsworth taumodulatesmrnatranscriptionalternativepolyadenylationprofilesofhnrnpschromatinremodelingandspliceosomecomplexes
AT annaellsworth taumodulatesmrnatranscriptionalternativepolyadenylationprofilesofhnrnpschromatinremodelingandspliceosomecomplexes
AT salomemcallen taumodulatesmrnatranscriptionalternativepolyadenylationprofilesofhnrnpschromatinremodelingandspliceosomecomplexes
AT salomemcallen taumodulatesmrnatranscriptionalternativepolyadenylationprofilesofhnrnpschromatinremodelingandspliceosomecomplexes
AT andrewrouth taumodulatesmrnatranscriptionalternativepolyadenylationprofilesofhnrnpschromatinremodelingandspliceosomecomplexes
AT andrewrouth taumodulatesmrnatranscriptionalternativepolyadenylationprofilesofhnrnpschromatinremodelingandspliceosomecomplexes
AT rakezkayed taumodulatesmrnatranscriptionalternativepolyadenylationprofilesofhnrnpschromatinremodelingandspliceosomecomplexes
AT rakezkayed taumodulatesmrnatranscriptionalternativepolyadenylationprofilesofhnrnpschromatinremodelingandspliceosomecomplexes
_version_ 1718373905324834816